- Home
- INBK vs PLX Comparison
INBK vs PLX Comparison
Compare INBK & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBK | PLX |
|---|---|---|
| Founded | 1999 | 1993 |
| Country | United States | United States |
| Employees | 355 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.3M | 159.5M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | INBK | PLX |
|---|---|---|
| Price | $23.92 | $2.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $23.25 | $12.00 |
| AVG Volume (30 Days) | 56.1K | ★ 833.1K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | $279.34 | $36.81 |
| Revenue Next Year | $12.97 | N/A |
| P/E Ratio | ★ N/A | $9.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.05 | $1.34 |
| 52 Week High | $28.51 | $3.19 |
Technical Indicators
Market Signals| Indicator | INBK | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 52.20 |
| Support Level | $23.26 | $2.06 |
| Resistance Level | $24.85 | $2.16 |
| Average True Range (ATR) | 0.79 | 0.13 |
| MACD | -0.17 | 0.02 |
| Stochastic Oscillator | 24.68 | 76.03 |
Price Performance
Historical ComparisonAbout INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.